Murray Korc

33.8k total citations · 6 hit papers
370 papers, 26.5k citations indexed

About

Murray Korc is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Murray Korc has authored 370 papers receiving a total of 26.5k indexed citations (citations by other indexed papers that have themselves been cited), including 240 papers in Molecular Biology, 207 papers in Oncology and 78 papers in Surgery. Recurrent topics in Murray Korc's work include Pancreatic and Hepatic Oncology Research (135 papers), TGF-β signaling in diseases (57 papers) and Pancreatitis Pathology and Treatment (43 papers). Murray Korc is often cited by papers focused on Pancreatic and Hepatic Oncology Research (135 papers), TGF-β signaling in diseases (57 papers) and Pancreatitis Pathology and Treatment (43 papers). Murray Korc collaborates with scholars based in United States, Switzerland and Germany. Murray Korc's co-authors include Helmut Friess, Jörg Kleeff, Markus W. Büchler, Helmut Frieß, Yoichiro Yamanaka, Toshiyuki Ishiwata, Marko Kornmann, Michael S. Kobrin, Markus W. Büchler and Denis C. Guttridge and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Murray Korc

370 papers receiving 26.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pancreatic cancer

2016 1.3k citations Murray Korc et al. profile →
Cancer-associated cachexia

2018 1.1k citations Murray Korc et al. profile →
Estrogen Binding, Receptor mRNA, and Biologic Response in Osteoblast-Like Osteosarcoma Cells

1988 667 citations Murray Korc et al. profile →
Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer

2016 337 citations Murray Korc et al. profile →
Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer

2017 324 citations Murray Korc, James L. Abbruzzese et al. profile →
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy

2021 150 citations Murray Korc et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Murray Korc United States	89	14.7k	12.3k	5.5k	4.4k	2.5k	370	26.5k
Nabeel Bardeesy United States	84	19.1k 1.3×	12.0k 1.0×	7.4k 1.3×	5.1k 1.2×	2.8k 1.1×	182	30.8k
Robert J. Coffey United States	98	16.7k 1.1×	7.8k 0.6×	6.4k 1.2×	5.9k 1.3×	2.8k 1.1×	416	34.1k
Anil K. Rustgi United States	73	9.9k 0.7×	9.6k 0.8×	4.1k 0.8×	4.8k 1.1×	2.2k 0.9×	302	20.2k
Shahin Rafii United States	99	21.4k 1.5×	10.8k 0.9×	6.9k 1.3×	4.8k 1.1×	6.1k 2.5×	304	39.1k
Yihai Cao Sweden	93	15.7k 1.1×	6.9k 0.6×	6.5k 1.2×	2.5k 0.6×	2.9k 1.2×	274	28.5k
Andres J. Klein–Szanto United States	83	12.0k 0.8×	7.0k 0.6×	4.9k 0.9×	1.9k 0.4×	1.7k 0.7×	383	21.3k
Lena Claesson‐Welsh Sweden	87	22.2k 1.5×	6.9k 0.6×	5.8k 1.1×	2.5k 0.6×	3.5k 1.4×	256	32.3k
Hong Wu United States	89	16.6k 1.1×	7.2k 0.6×	4.5k 0.8×	1.6k 0.4×	3.1k 1.2×	204	26.2k
Harold L. Moses United States	103	24.6k 1.7×	14.7k 1.2×	6.6k 1.2×	3.2k 0.7×	4.9k 2.0×	317	41.0k
Christine A. Iacobuzio–Donahue United States	87	13.3k 0.9×	17.3k 1.4×	9.1k 1.6×	4.8k 1.1×	3.1k 1.3×	285	29.5k

Countries citing papers authored by Murray Korc

Since Specialization

Citations

This map shows the geographic impact of Murray Korc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray Korc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray Korc more than expected).

Fields of papers citing papers by Murray Korc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray Korc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray Korc. The network helps show where Murray Korc may publish in the future.

Co-authorship network of co-authors of Murray Korc

This figure shows the co-authorship network connecting the top 25 collaborators of Murray Korc. A scholar is included among the top collaborators of Murray Korc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray Korc. Murray Korc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jeon, Christie Y., Mustafa A. Arain, Murray Korc, Richard A. Kozarek, & Anna Evans Phillips. (2024). Bidirectional relationship between acute pancreatitis and pancreatic cancer. Current Opinion in Gastroenterology. 40(5). 431–438. 2 indexed citations

Sasaki, Norihiko, Fujiya Gomi, Hisashi Yoshimura, et al.. (2020). FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer. Cancers. 12(10). 2976–2976. 22 indexed citations

Korc, Murray. (2019). Pathogenesis of Pancreatic Cancer-related Diabetes Mellitus: Quo Vadis?. PMC. 1 indexed citations

Gore, Jesse, et al.. (2016). Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model. Cancer Letters. 379(1). 143–153. 35 indexed citations

Logsdon, Derek P., Meihua Luo, Safi Shahda, et al.. (2016). Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models. Molecular Cancer Therapeutics. 15(11). 2722–2732. 93 indexed citations

Shannon, Harlan E., Melissa L. Fishel, Jingwu Xie, et al.. (2014). Longitudinal Bioluminescence Imaging of Primary Versus Abdominal Metastatic Tumor Growth in Orthotopic Pancreatic Tumor Models in NSG Mice. Pancreas. 44(1). 64–75. 8 indexed citations

Ueda, Junji, Yoko Matsuda, Kazuya Yamahatsu, et al.. (2014). Epithelial Splicing Regulatory Protein 1 is a Favorable Prognostic Factor in Pancreatic Cancer that Attenuates Pancreatic Metastases. PMC. 1 indexed citations

Slee, Roger B., Brenda R. Grimes, Jesse Gore, et al.. (2013). Selective Inhibition of Pancreatic Ductal Adenocarcinoma Cell Growth by the Mitotic MPS1 Kinase Inhibitor NMS-P715. Molecular Cancer Therapeutics. 13(2). 307–315. 39 indexed citations

Liu, Fang & Murray Korc. (2012). Cdk4/6 Inhibition Induces Epithelial–Mesenchymal Transition and Enhances Invasiveness in Pancreatic Cancer Cells. Molecular Cancer Therapeutics. 11(10). 2138–2148. 102 indexed citations

10.

Cubillos‐Ruiz, Juan R., Jason R. Baird, Amelia J. Tesone, et al.. (2012). Reprogramming Tumor-Associated Dendritic Cells In Vivo Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer. Cancer Research. 72(7). 1683–1693. 124 indexed citations

11.

Preis, Meir, Timothy B. Gardner, Stuart R. Gordon, et al.. (2011). MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 17(17). 5812–5821. 125 indexed citations

12.

Sempere, Lorenzo F., Meir Preis, Todd Yezefski, et al.. (2010). Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors. Clinical Cancer Research. 16(16). 4246–4255. 90 indexed citations

13.

Seeley, E. Scott, Catherine Carrière, Tobias Goetze, Daniel S. Longnecker, & Murray Korc. (2009). Pancreatic Cancer and Precursor Pancreatic Intraepithelial Neoplasia Lesions Are Devoid of Primary Cilia. Cancer Research. 69(2). 422–430. 217 indexed citations

14.

Liu, Xi, Lorenzo F. Sempere, Fabrizio Galimberti, et al.. (2009). Uncovering Growth-Suppressive MicroRNAs in Lung Cancer. Clinical Cancer Research. 15(4). 1177–1183. 151 indexed citations

15.

Asano, Takayuki, Yixin Yao, Ronghua Zhang, et al.. (2009). Activator Protein-1 Has an Essential Role in Pancreatic Cancer Cells and Is Regulated by a Novel Akt-Mediated Mechanism. Molecular Cancer Research. 7(5). 745–754. 21 indexed citations

16.

Frieß, Helmut, Li Wang, Zhaowen Zhu, et al.. (1999). Growth Factor Receptors Are Differentially Expressed in Cancers of the Papilla of Vater and Pancreas. Annals of Surgery. 230(6). 767–767. 66 indexed citations

17.

Maurer, Christoph A., Helmut Frieß, Bodo Kretschmann, et al.. (1998). Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Human Pathology. 29(8). 771–777. 114 indexed citations

18.

Kornmann, Marko, Toshiyuki Ishiwata, Nadir Arber, H. G. Beger, & Murray Korc. (1998). Increased Cyclin D1 Expression in Chronic Pancreatitis. Pancreas. 17(2). 158–162. 16 indexed citations

19.

Frieß, Helmut, Yoichiro Yamanaka, Markus W. Büchler, et al.. (1994). A Subgroup of Patients with Chronic Pancreatitis Overexpress the c-erb B-2 Protooncogene. Annals of Surgery. 220(2). 183–192. 32 indexed citations

20.

Raitano, Arthur, Philip Scuderi, & Murray Korc. (1991). Upregulation of Interferon-γ Binding by Tumor Necrosis Factor and Lymphotoxin: Disparate Potencies of the Cytokines and Modulation of Their Effects by Phorbol Ester. Journal of Interferon Research. 11(1). 61–67. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact